Fitbit Inc. FIT, +0.28% shares are up 3.7% in premarket trading Thursday after the company announced a partnership with the Bristol-Myers Squibb-Pfizer Alliance focused on the detection of atrial fibrillation using Fitbit devices. As atrial fibrillation is a risk factor for stroke, the goal is to use technology to help patients detect this form of irregular heartbeat early on. Bristol-Myers Squibb Co. BMY, -0.76% shares are up 0.4% premarket, while Pfizer Inc. PFE, -0.68% shares are up 0.1%. Fitbit's stock has dropped 15% over the past three months as the S&P 500 SPX, -1.85% has gained 0.2%.